Breathe Well Live Well
 AARP News |
Global Markets for Asthma, COPD Drugs to Hit $47 Billion in 2017
news Stories A new market research report projects growth for the global asthma and chronic obstructive pulmonary disease prescription drug market. The report, published by RnRMarketResearch.com, valued the market at $34.9 billion in 2011 and projects it will reach … Global Markets for Asthma & COPD Drugs to hit $47 Billion in 2017 Meet held to discuss respiratory diseases |
View full post on asthma – Google News
 In-PharmaTechnologist.com |
Prosonix teams with ICL to assess MCPs for COPD and asthma
In-PharmaTechnologist.com Prosonix aims to develop new treatments for respiratory diseases though an R&D accord formed with Imperial College London (ICL). |
View full post on asthma – Google News
|
Fire smoke can exacerbate asthma, COPD
Rapid City Journal She was diagnosed with asthma in 1985 and more recently with vocal cord dysfunction, a condition that causes her vocal cords to constrict, blocking the flow of air to the lungs. Rasmussen said her asthma is caused not by allergies, but from irritants … |
View full post on asthma – Google News
|
Global asthma and COPD drug market to reach nearly $27 billion in …
The Pharma Letter The global asthma and chronic obstructive pulmonary disease (COPD) market was worth $25.102 billion in 2010, and is expected to reach $26.965 billion in … |
View full post on asthma – Google News
|
Asthma and COPD Drug Market Expected to Reach USD 26965.5 …
MarketWatch (press release) The asthma market is witnessing intense competition due to the increased entry of inhaled corticosteroids, combinational therapies, and beta-agonists. |
View full post on asthma – Google News
Relationships between impulse oscillometry, spirometry and dyspnoea in COPD.
J R Coll Physicians Edinb. 2012 Jun;42(2):111-5
Authors: Anderson WJ, Lipworth BJ
Abstract
Background: Severity of chronic obstructive pulmonary disease (COPD) is based either on symptoms/disability or lung function, which have no discernible correlation. We hypothesised that impulse oscillometry (IOS), a non-effortdependent measure of central and peripheral airway mechanics, could correlate to dyspnoea in COPD. Methods: We analysed screening data from 57 COPD patients who had spirometry, IOS and Medical Research Council dyspnoea score (MRC) measurements. We searched for predictors or correlations of MRC from IOS, spirometry and demographics. Results: MRC had no significant predictors or correlations from IOS, spirometry or demographics (possibly excepting smoking history, p=0.05). IOS correlated significantly with spirometry: FEV1 and FEF25-75 vs. R5-R20 (peripheral airway resistance), r= -0.499, p > 0.001 and r= -0.397, p= 0.002 respectively. Conclusion: MRC is not related to IOS or spirometry in COPD. IOS correlates well with spirometry, particularly peripheral airway resistance (R5-R20). IOS is useful, but does not provide a link between symptoms and pulmonary function measurements.
PMID: 22693693 [PubMed – in process]
View full post on pubmed: asthma
|
COPD Tops Asthma as the Focus Indication for Next Generation Respiratory …
MarketWatch (press release) COPD has superseded asthma as the lead indication in the market race, most likely due to the FDA's new safety controls pertaining to limited use of all LABA-containing drugs in asthma as well as the unmet need for improved therapies for COPD," states … |
View full post on asthma – Google News
|
MediciNova To Release Asthma And COPD Trial Results In Q2
Seeking Alpha "We'll have Phase 2b results by the end of May treating patients with acute exacerbations of asthma (AEA) in the emergency room and results by June from a Phase Ib multi-dose trial in patients with moderate-to-severe chronic obstructive pulmonary … |
View full post on asthma – Google News
|
GSK, FivePrime partner to discover new asthma and COPD treatments
MedCity News Under the new partnership, the companies aim to find new ways to treat asthma and chronic obstructive pulmonary disorder, or COPD. Over the next four years, privately held FivePrime stands to gain up to $30 million from the new deal in the form of … Five Prime strikes deal with GSK for asthma drug Five Prime, GSK sign strategic drug discovery alliance Five Prime Therapeutics Announces Second Strategic Alliance With GlaxoSmithKline |
View full post on asthma – Google News
|
Family fun ride helps Asthma and COPD Education Center
Bakersfield Now The Asthma and COPD Education Center is gearing up for the Woody Y Century & Family Fun Ride. The event is Saturday at The Park at River Walk on Stockdale Highway. It begins and ends at River Walk, and there are five routes to choose from. |
View full post on asthma – Google News